Where does Revalesio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Revalesio's 6 recorded funding rounds.

Premier Alternatives

Revalesio

Tacoma, WA · Founded 2000 · Privately Held (backing)

Developer of an anti-inflammatory therapeutic drug designed to treat a variety of neurological diseases. Revalesio is based in Tacoma, WA and was founded in 2000. Its last reported valuation was $86.4 million in Jul 2020. It has raised $113 million across 6 recorded rounds; the latest was a $38.9 million early-stage round in May 2022.

Last reported valuation

$86.4M

Oct 2026

Priced at

—

Total raised

$112.8M

Last round

Early Stage VC

May 2022

Cap table — not yet on record

Revalesio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Revalesio with a free account

·Watch Revalesio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Revalesio

Where does Revalesio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Revalesio's 6 recorded funding rounds.